Contact Us

Antitope Ltd
Babraham Research Campus
Babraham
Cambridge CB22 3AT
United Kingdom

Telephone: +44(0) 1223 496190
Fax: +44(0) 1223 496191
Email: This e-mail address is being protected from spambots. You need JavaScript enabled to view it

PolyTherics Ltd
The London Bioscience Innovation Centre
2 Royal College Street
London NW1 0NH
United Kingdom

Telephone: +44 (0)20 7691 4927
Email: This e-mail address is being protected from spambots. You need JavaScript enabled to view it

Whole Protein Immunogenicity Testing

EpiScreen™ Time Course T Cell Assays
A typical study uses PBMCs from a minimum of 50 donors which are carefully selected to provide a distribution of HLA-DR allotypes which represents the human population relevant to the study. Whole proteins are added to bulk cultures of pre-processed PBMCs, and T cell activation assay measurements are performed between days 5 and 8 post-stimulation. Proliferation and IL-2 secretion are two early markers of T cell activation and are measured using 3H TdR incorporation and EliSpot®, respectively. Strong correlation between these markers enables the detection of CD4+ effector T cell activation and discriminates between T cell effector and regulatory responses.

EpiScreen™ DC:T Cell Assays
For proteins which modulate T cell responses, the alternative EpiScreen™ “DC:T Cell” assay format is used whereby dendritic cells (DC) are separated from CD4+ T cells in the PBMCs prior to addition of the test sample. Immature DC are produced in vitro and are incubated with the test protein to enable protein uptake and intracellular processing of peptide T cell epitopes (‘antigen loading’). Excess protein is removed by washing and the DC are induced to a fully mature phenotype in vitro. Autologous CD4+ T cells are co-cultured with the mature ‘antigen loaded’ DC for 7 days prior to measuring T cell stimulation, typically by proliferation (3H TdR) and IL-2 secretion (EliSpot®).